In addition to E3-ubiquitin ligases, deubiquitinating enzymes (DUB) also modulate the stability of ERα protein in breast cancer, which functions to cleave ubiquitin chains from ERα proteins to modulate its degradation. Here, ZUP1 is linked to breast cancer.